Skip to main content
. 2022 Jun 9;12(12):1507. doi: 10.3390/ani12121507

Table 4.

Summary of treatments used for the dogs in the study population as well as information concerning co-morbidities by treatment outcome group. Other immunosuppressive treatment include cyclosporine, azathioprine, chlorambucil, budesonide, and sulfasalazine/olsalazine. Gastroprotectant treatment included proton pump inhibitors, sucralfate, and/or famotidine. Notice that a dog may have received more than one of the listed medical treatments.

Variable Overall
(n = 814)
Food Responsive
(n = 93)
Immunosuppressant Responsive
(n = 449)
Antibiotic Responsive
(n = 9)
Non Responsive
(n = 42)
Non Classified
(n = 221)
Treatment Hydrolyzed diet 563/814 49/93 323/449 7/9 26/42 158/221
Novel protein diet 106/814 19/93 57/449 1/9 5/42 24/221
Gastrointestinal diet 111/814 23/93 50/449 1/9 8/42 29/221
Home cooked diet 18/814 0/93 10/449 0/9 1/42 7/221
Other diet 14/814 2/93 9/449 0/9 2/42 1/221
Prednisolone/methylprednisolone 668/814 6/93 446/449 7/9 39/42 170/221
Budesonide 44/814 0/93 23/449 0/9 2/42 19/221
Cyclosporine 81/814 1/93 50/449 0/9 8/42 22/221
Chlorambucil 11/814 0/93 2/449 0/9 2/42 7/221
Sulfasalazine/olsalazine 20/814 0/93 4/449 2/9 4/42 10/221
Prednisolone/methylprednisolone combined with other immunosuppressive treatment 132/814 1/93 72/449 2/9 15/42 42/221
Antibiotic treatment 341/814 8/93 138/449 9/9 28/42 158/221
Gastroprotectant treatment 512/814 48/93 299/449 5/9 28/42 132/221
Cobalamin supplementation 380/814 36/93 216/449 3/9 27/42 98/221
Folic acid supplementation 189/814 21/93 111/449 1/9 12/42 44/221
Probiotics 91/814 5/93 46/449 2/9 7/42 31/221
Other diseases/medication Other diseases 453/814 56/93 266/449 5/9 15/42 111/221
Other medication 281/814 18/93 158/449 4/9 20/42 81/221